Stock(600222)Hot line:010-61006450


Come and join us in the new era of pharmaceutical industry!

Company History

Company History
  • 2021

    Established a branch of CMC Institute in Chongqing, build an integrated biomedical base in Chongqing
    Hangzhou Research Institute (the first high-end pediatric Preparation Research Institute in China) started construction
    Zhengzhou Small Molecule CDMO Platform was inaugurated
    CNAS Certification for the Analytical Testing Center
    Standing director unit of China Society of Research Hospitals and Vice chairman unit of the Special Committee of New Drug Creation of Integrated Traditional Chinese and Western Medicine
    First Place of Top Chinese Pharmaceutical R & D Companies in 2020, Independent Innovation Pioneer Private Enterprise, High Growth 50 Enterprise, Law-abiding & Honest Enterprise

  • 2020

    Financing 130 million yuan, created unique Leadingpharm CXO Service System
    The Construction of Zhengzhou Base (including New Drug Screening and Testing Platform, Drug Evaluation Platform, Macromolecular Pilot and Mass Production Service Platform, Small Molecular CMC Preparation Research and Production Platform, Cell Technology Service Platform and Clinical CRO Platform) was completed
    Established 6 high-end preparation platforms
    Held the Second Zhengzhou International Biological Innova-tion and Development Summit Forum
    Co-opted as the Vice President Unit of All-China Federation of Industry and Commerce Pharmaceutical Chamber of Commerce
    Deep Blue Occean clinical business expansion, creating the first person in the clinical CRO team of cell and gene therapy drugs

  • 2019

    The construstion of Miyun Research Institute was completed
    Built joint laboratories with Shimadzu China, Thermo Fisher
    Passed the ISO9001 Quality Management System Certification
    Passed the Intellectual Property Management System Certification
    Beijing Municipal Enterprise Science and Technology R&D Institution
    No. 1 in China Pharmaceutical R&D Company

  • 2016

    Establish Consistency Evaluation Center
    Establish the first international IVIVR center in China
    Won the "Top Three Chinese Pharmaceutical R & D Companies"

  • 2015

    Listed on the Shanghai Stock Exchange (stock code 600222)

  • 2010

    High-tech enterprise certification

  • 2005

    Business Vision:We make China a world-class player in pharmaceutical technology development and production process!
    Business Culture:Loyalty, Thinking, Construction, Commitment, Sharing